U.S., Jan. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07322445) titled 'Multi-modal Imaging of Myofascial Pain - Phase 2' on Oct. 06, 2025.
Brief Summary: The goal of this study is to evaluate imaging biomarkers for quantitative assessments of myofascial pain and determine their ability to monitor treatment response and predict clinical outcomes.
Study Start Date: Oct. 01, 2025
Study Type: INTERVENTIONAL
Condition:
Myofascial Pain
Intervention:
DRUG: 50/50 Mixture of Lidocaine 1% injection + Bupivacaine 0.25% Injectable Solution
Treatment Group: Receives trigger-point injection with a 50/50 mixture of 1% lidocaine and 0.25% bupivacaine
PROCEDURE: Dry Needling
Single session of dry needling to th...